Protective efficacy of crude virus-like particle vaccine against HPAI H5N1 in chickens and its application on DIVA strategy

Influenza and other Respiratory Viruses

Volumn 7, Issue 3, 2013, Pages 340-348

  Park, Jae Keun ^a   Lee, Dong Hun ^a   Youn, Ha Na ^a   Kim, Myeong Seob ^a   Lee, Yu Na ^a   Yuk, Seong Su ^a   Lim, Tae Hyun ^a   Jang, Jun Hyuk ^a   Kwon, Jung Hoon ^a   Kim, Byoung Yoon ^a   Kang, Sang Moo ^b   Seong, Baik Lin ^c   Lee, Joong Bok ^a   Park, Seung Yong ^a   Choi, In Soo ^a   Song, Chang Seon ^a  

^a Konkuk University   (South Korea)

^b GEORGIA STATE UNIVERSITY   (United States)

^c Yonsei University   (South Korea)

Author keywords

Chicken; DIVA; HPAI; Vaccine; VLP

Indexed keywords

BACULOVIRUS VECTOR; VIRUS LIKE PARTICLE VACCINE;

ARTICLE; AVIAN INFLUENZA; AVIAN INFLUENZA VIRUS; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; EXPRESSION VECTOR; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEOTIDE SEQUENCE; POULTRY; PRIORITY JOURNAL; PROTECTION; SEROCONVERSION; SEROLOGY; VACCINE PRODUCTION; VIRUS SHEDDING; WILD TYPE;

ANIMALS; ANTIBODIES, VIRAL; CHICKENS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY DISEASES; SPECIFIC PATHOGEN-FREE ORGANISMS; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE;

EID: 84876460117     PISSN: 17502640     EISSN: 17502659     Source Type: Journal    
DOI: 10.1111/j.1750-2659.2012.00396.x     Document Type: Article

References (41)

1. World-Organization-for-Animal-Health. OIE Terrestrial Manual, CHAPTER 2.3.4, AVIAN INFLUENZA. Available at http://www.oie.int/international-standard-setting/terrestrial-manual/access-online/ (Accessed 1 December 2011).
2. Swayne DE. Avian influenza vaccines and therapies for poultry. Comp Immunol Microbiol Infect Dis 2009; 32:351-363.
3. Xu X, Subbarao K, Cox NJ, Guo Y. Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 1999; 261:15-19.
4. World Health Organization. Cumulative number of confirmed human cases of avian influenza A(H5N1) reported to WHO. Available at http://www.who.int/influenza/human_animal_interface/H5N1_cumulative_table_archives/en/index.html.
5. Butler D. Vaccination will work better than culling, say bird flu experts. Nature 2005; 434:810.
6. Food-and-Agriculture-Organization. OIE/FAO International Scientific Conference on Avian Influenza, OIE Paris, France. Available at http://www.fao.org/avianflu/documents/OIE_FAO_Recom_05.pdf (Accessed 1 December 2011).
7. World-Organization-for-Animal-Health. AVIAN INFLUENZA VACCINATION. Available at http://www.oie.int/eng/info_ev/Other%20Files/A_Guidelines%20on%20AI%20vaccination.pdf (Accessed 1 December 2011).
8. Food-and-Agriculture-Organization. FAO Recommendations on the Prevention, Control and Eradication of Highly Pathogenic Avian Influenza (HPAI) in Asia. Available at http://www.fao.org/docs/eims/upload/165186/FAOrecommendationsonHPAI.pdf (Accessed 1 December 2011).
9. Abbott A, Pearson H. Fear of human pandemic grows as bird flu sweeps through Asia. Nature 2004; 427:472-473.
10. Capua I, Terregino C, Cattoli G, Mutinelli F, Rodriguez JF. Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol 2003; 32:47-55.
11. Suarez DL. Overview of avian influenza DIVA test strategies. Biologicals 2005; 33:221-226.
12. Roldao A, Mellado MC, Castilho LR, Carrondo MJ, Alves PM. Virus-like particles in vaccine development. Expert Rev Vaccines 2010; 9:1149-1176.
13. Kang SM, Compans RW. Host responses from innate to adaptive immunity after vaccination: molecular and cellular events. Mol Cells 2009; 27:5-14.
14. Galarza JM, Latham T, Cupo A. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge. Viral Immunol 2005; 18:365-372.
15. Kang SM, Song JM, Quan FS, Compans RW. Influenza vaccines based on virus-like particles. Virus Res 2009; 143:140-146.
16. Quan FS, Huang C, Compans RW, Kang SM. Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 2007; 81:3514-3524.
17. Kang SM, Pushko P, Bright RA, Smith G, Compans RW. Influenza virus-like particles as pandemic vaccines. Curr Top Microbiol Immunol 2009; 333:269-289.
18. Bright RA, Carter DM, Crevar CJ et al. Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PLoS ONE 2008; 3:e1501.
19. Kang SM, Yoo DG, Lipatov AS et al. Induction of long-term protective immune responses by influenza H5N1 virus-like particles. PLoS ONE 2009; 4:e4667.
20. Mahmood K, Bright RA, Mytle N et al. H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine 2008; 26:5393-5399.
21. Perrone LA, Ahmad A, Veguilla V et al. Intranasal vaccination with 1918 influenza virus-like particles protects mice and ferrets from lethal 1918 and H5N1 influenza virus challenge. J Virol 2009; 83:5726-5734.
22. Prel A, Le Gall-Recule G, Jestin V. Achievement of avian influenza virus-like particles that could be used as a subunit vaccine against low-pathogenic avian influenza strains in ducks. Avian Pathol 2008; 37:513-520.
23. Lee DH, Park JK, Lee YN et al. H9N2 avian influenza virus-like particle vaccine provides protective immunity and a strategy for the differentiation of infected from vaccinated animals. Vaccine 2011; 29:4003-4007.
24. Suarez DL. Avian influenza: our current understanding. Anim Health Res Rev 2010; 11:19-33.
25. Hoffmann E, Stech J, Guan Y, Webster RG, Perez DR. Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol 2001; 146:2275-2289.
26. King LA, Hitchman R, Possee RD. Recombinant baculovirus isolation. Methods Mol Biol 2007; 388:77-94.
27. Kalthoff D, Giritch A, Geisler K et al. Immunization with plant-expressed hemagglutinin protects chickens from lethal highly pathogenic avian influenza virus H5N1 challenge infection. J Virol 2010; 84:12002-12010.
28. Terregino C, Toffan A, Cilloni F et al. Evaluation of the protection induced by avian influenza vaccines containing a 1994 Mexican H5N2 LPAI seed strain against a 2008 Egyptian H5N1 HPAI virus belonging to clade 2.2.1 by means of serological and in vivo tests. Avian Pathol 2010; 39:215-222.
29. Bublot M, Le Gros FX, Nieddu D, Pritchard N, Mickle TR, Swayne DE. Efficacy of two H5N9-inactivated vaccines against challenge with a recent H5N1 highly pathogenic avian influenza isolate from a chicken in Thailand. Avian Dis 2007; 51:332-337.
30. Lee YJ, Sung HW, Choi JG et al. Effects of homologous and heterologous neuraminidase vaccines in chickens against H5N1 highly pathogenic avian influenza. Avian Dis 2007; 51:476-478.
31. Terregino C, Toffan A, Beato MS, De Nardi R, Drago A, Capua I. Conventional H5N9 vaccine suppresses shedding in specific-pathogen-free birds challenged with HPAI H5N1 A/chicken/Yamaguchi/7/2004. Avian Dis 2007; 51:495-497.
32. Spackman E, Senne DA, Bulaga LL et al. Development of real-time RT-PCR for the detection of avian influenza virus. Avian Dis 2003; 47:1079-1082.
33. Sylte MJ, Suarez DL. Influenza neuraminidase as a vaccine antigen. Curr Top Microbiol Immunol 2009; 333:227-241.
34. Pfeiffer J, Suarez DL, Sarmento L, To TL, Nguyen T, Pantin-Jackwood MJ. Efficacy of commercial vaccines in protecting chickens and ducks against H5N1 highly pathogenic avian influenza viruses from Vietnam. Avian Dis 2010; 54:262-271.
35. Terregino C, De Nardi R, Guberti V et al. Active surveillance for avian influenza viruses in wild birds and backyard flocks in Northern Italy during 2004 to 2006. Avian Pathol 2007; 36:337-344.
36. Swayne DE. Principles for vaccine protection in chickens and domestic waterfowl against avian influenza: emphasis on Asian H5N1 high pathogenicity avian influenza. Ann N Y Acad Sci 2006; 1081:174-181.
37. Soda K, Sakoda Y, Isoda N et al. Development of vaccine strains of H5 and H7 influenza viruses. Jpn J Vet Res 2008; 55:93-98.
38. Sasaki T, Kokumai N, Ohgitani T et al. Long lasting immunity in chickens induced by a single shot of influenza vaccine prepared from inactivated non-pathogenic H5N1 virus particles against challenge with a highly pathogenic avian influenza virus. Vaccine 2009; 27:5174-5177.
39. Hwang SD, Kim HS, Cho SW, Seo SH. Single dose of oil-adjuvanted inactivated vaccine protects chickens from lethal infections of highly pathogenic H5N1 influenza virus. Vaccine 2011; 29:2178-2186.
40. Wang BZ, Quan FS, Kang SM, Bozja J, Skountzou I, Compans RW. Incorporation of membrane-anchored flagellin into influenza virus-like particles enhances the breadth of immune responses. J Virol 2008; 82:11813-11823.
41. Pushko P, Pearce MB, Ahmad A et al. Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. Vaccine 2011; 29:5911-5918.